548.9500 4.15 (0.76%)
NSE Jun 30, 2025 12:03 PM
Volume: 77,925
 

548.95
0.76%
Prabhudas Lilladhar
HealthCare Global Enterprises' (HCG) Q4 consolidated EBITDA grew by 15% YoY to Rs1.1bn; in line with our estimate. The company's asset-light approach with a focus on partnerships has made its business model more capital efficient and scalable, in our view. We believe the strategic investment by KKR will bring in more operational and financial efficiency. Currently, HCG enjoys 13-14% pre IND AS margin, which is lower than its peers. We expect KKR to drive growth through bed expansion, rationalization of existing assets and scale up of...
Healthcare Global Enterprises Ltd. is trading below its 30 day SMA of 554.3
More from Healthcare Global Enterprises Ltd.
Recommended